Moncrief In The Media 

Actress Angelina Jolie revealed Tuesday that she had a double mastectomy a few weeks ago. Jolie said that after genetic testing she learned she carries the "faulty" BRCA1 gene and had an 87 percent chance of getting the disease herself.  Moncrief Cancer Institute partners with UT Southwestern to provide genetic testing and counseling.  Genetic Counseling Supervisor Linda Robinson, who has seen more than five thousand genetic patients, was interviewed on the 6:00 p.m. KTXD-TV News recently:    
Interview with Linda Robinson on KTXD-TV

Mayor's Rolling Town Hall Visits Moncrief Promoting Fitness and Cancer Prevention

Mayor Betsy Price brought her Rolling Town Hall Bike Tour to Moncrief on Wednesday, May 1.
Medical Director Keith Argenbright, MD, welcomed the crowd of about 100 -- including Paul Paine of Fort Worth South and FWISD Superintendent Walter Dansby who rode with the Daggett Middle School Decathlon Team. View the event here:

Star-Telegram - Moncrief Genetic Testing

WFAA - Moncrief Opens in Fort Worth

D-Magazine - Moncrief -  New Facility

Telemundo - Instituto-de-cancer-moncrief

FTW-Business Press-Moncrief

We invite you to visit us at our new $22 million Cancer center that expands cancer support services at 400 W. Magnolia Ave. in Fort Worth's Medical District.

At a dedication ceremony on Nov. 19, W.A. “Tex” Moncrief, Jr. was joined by Tarrant County Judge Glen Whitley, Fort Worth Mayor Betsy Price and leaders from the Moncrief Cancer Foundation, Moncrief Cancer Institute and UT Southwestern Medical Center.

The new 60,000-square-foot facility located on four acres houses our Community Survivorship Clinic, along with an expanded fitness center, demonstration kitchen, and an education center featuring a 90 seat auditorium for physician and public seminars.

The building allows us to provide digital mammography services for uninsured and insured patients, genetic counseling and risk assessment, and live telemedicine video links connecting our genetic counselors to patients in surrounding communities.  If desired by the patient, we will also offer evaluations for participants in UT Southwestern-based clinical trials of newly developed drugs.